Weight loss medications can reduce appetite, boost metabolism, block fat absorption, and improve blood sugar control
The 4.5 mg dose produced 10.8% mean weight loss at 26 weeks
Patients with low risk may proceed with standard interventions and periodic monitoring, for instance quarterly app-based check-ins or brief clinical interviews
Every program starts with a conversation about what you actually want to change, a review of your labs and history, and a treatment plan built around the goals that matter to you
Along the way, youll hear about the biology of the GLP-1 molecule and its related peptides, learn more about how GLP-1 agonists promote glycemic control, weight loss, and cardiometabolic health, and explore the current body of literature supporting the individualized application of these medications to patients with diabetes, obesity, and/or ASCVD